- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 59/50 - Mandelic acid
Patent holdings for IPC class C07C 59/50
Total number of patents in this class: 45
10-year publication summary
|
4
|
4
|
2
|
3
|
0
|
1
|
2
|
5
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2226 |
5 |
| BASF SE | 21308 |
2 |
| Sandoz AG | 1412 |
2 |
| Actavis Group PTC ehf | 392 |
2 |
| Teva Pharmaceuticals USA, Inc. | 636 |
2 |
| Zhejiang Jiuzhou Pharma Science & Technology Co., Ltd. | 9 |
2 |
| Crinetics Pharmaceuticals, Inc. | 129 |
2 |
| Boehringer Ingelheim International GmbH | 4493 |
1 |
| Kaneka Corporation | 4713 |
1 |
| Abbvie Inc. | 1824 |
1 |
| The Board of Trustees of the University of Illinois | 2746 |
1 |
| Takeda Pharmaceutical Company Limited | 2710 |
1 |
| Arch Pharmalabs Limited | 16 |
1 |
| Cadila Healthcare Limited | 291 |
1 |
| Celgene Corporation | 1415 |
1 |
| China State Institute of Pharmaceutical Industry | 21 |
1 |
| Cipla Limited | 478 |
1 |
| The First Affiliated Hospital, Third Military University, PLA | 1 |
1 |
| Krka, D.d., Novo Mesto | 97 |
1 |
| Laboratoriya Bio Zet, LLC | 4 |
1 |
| Other owners | 15 |